Thrombocytopenia in the ICU: Disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know

Critical Care

Volumn 22, Issue 1, 2018, Pages

  Vincent, Jean Louis ^a   Castro, Pedro ^b   Hunt, Beverley J ^c   Jörres, Achim ^d   Praga, Manuel ^e   Rojas Suarez, Jose ^f   Watanabe, Eizo ^g  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF BARCELONA   (Spain)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f UNIVERSIDAD DE CARTAGENA   (Colombia)

^g Eastern Chiba Medical Center   (Japan)

Author keywords

Disseminated intravascular coagulation; Hemolytic uremic syndrome; Intensive care unit; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ALGORITHM; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD PRESSURE; BLOOD SMEAR; COOMBS TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EDITORIAL; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; INTENSIVIST; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SHOCK; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; DISSEMINATED INTRAVASCULAR COAGULATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INTENSIVE CARE UNITS; THROMBOCYTOPENIA; THROMBOTIC MICROANGIOPATHIES;

EID: 85048480478     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-018-2073-2     Document Type: Editorial

References (15)

1. Ali N, Auerbach HE. New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach. J Community Hosp Intern Med Perspect. 2017;7:157-67.
2. Boral BM, Williams DJ, Boral LI. Disseminated intravascular coagulation. Am J Clin Pathol. 2016;146:670-80.
3. Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyo JM, Macia M, Mendizabal S, Praga M, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2015;35:421-47.
4. Van der Linden T, Souweine B, Dupic L, Soufir L, Meyer P. Management of thrombocytopenia in the ICU (pregnancy excluded). Ann Intensive Care. 2012;2:42.
5. Cartin-Ceba R, Kojicic M, Li G, Kor DJ, Poulose J, Herasevich V, Kashyap R, Trillo-Alvarez C, Cabello-Garza J, Hubmayr R, et al. Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community. Chest. 2011;140:1447-55.
6. Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390:681-96.
7. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158:323-35.
8. Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, et al. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010;5:e10208.
9. Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clin Adv Hematol Oncol. 2016;14(Suppl 11):2-15.
10. Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4:e157-e64.
11. Azoulay E, Knoebl P, Garnacho-Montero J, Rusinova K, Galstian G, Eggimann P, Abroug F, Benoit D, von Bergwelt-Baildon M, Wendon J, et al. Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome. Chest. 2017;152:424-34.
12. Iba T, Di Nisio M, Thachil J, Wada H, Asakura H, Sato K, Kitamura N, Saitoh D. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity. Crit Care. 2016;20:287.
13. Walle JV, Delmas Y, Ardissino G, Wang J, Kincaid JF, Haller H. Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment. J Nephrol. 2017;30:127-34.
14. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102:60-8.
15. Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood. 2013;122:1487-93.